Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380

Journal of Nuclear Medicine

Volumn 40, Issue 8, 1999, Pages 1374-1380

  Valette, Héric ^a,b   Bottlaender, Michel ^a   Dollé, Frédéric ^a   Guenther, Ilonka ^a   Fuseau, Chantal ^a   Coulon, Christine ^a   Ottaviani, Michele ^a   Crouzel, Christian ^a  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^b DIF   (France)

Author keywords

3 2(S) 2 azetidinylmethoxy pyridine; 18F fluorine; Brain; Nicotinic receptors; Nonhuman primates; PET

Indexed keywords

3 (2 AZETIDINYLMETHOXY)PYRIDINE; 3 [2 (S) 2 AZETIDINYLMETHOXY]PYRIDINE; FLUORINE 18; NICOTINIC RECEPTOR; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BABOON; BINDING AFFINITY; CEREBELLUM; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG SAFETY; FRONTAL CORTEX; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; LETHAL DOSE; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THALAMUS;

ANIMALS; AZETIDINES; BRAIN; FLUORINE RADIOISOTOPES; LIGANDS; MALE; MICE; PAPIO; RECEPTORS, NICOTINIC; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032857633     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rinne JO, Myllykylä R, Lönnberg P, Marjamäki P. A postmortem study of brain nicotonic receptors in Parkinson's and Alzheimer's disease. Brain Res. 1991;547: 167-170.
2. Gotti C, Fornasari D, Clementi F. Human neuronal nicotinic receptors. Prog Neurobiol. 1997;53:199-237.
3. 11C: synthesis and distribution kinetics in animals. Eur J Nucl Med. 1976;1:255-258.
4. 11C] cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET. Nucl Med Biol. 1992;19:871-880.
5. 11C-nicotine in the human brain: difficulties in vizualizing specific receptor binding in vivo. Psychopharmacology. 1994;115:31-36.
6. 3H-nicotine in the mouse brain. Life Sci. 1989;44:1123-1132.
7. 11C] methyl-cytisine. Nucl Med Commun. 1997;18:164-168.
8. 11C]A-84543: an enantioselective ligand for in vivo studies of neuronal nicotinic acetylcholine receptors. Life Sci. 1998;63:PL13-PL18.
9. Badio B, Daly JW. Epibatidine: a potent analgesic and nicotinic agonist. Mol Pharmacol. 1994;45:563-569.
10. 18F]FHP for PET imaging of nicotinic acetylcholine receptors. J Nucl Med. 1997;38:1250-1265.
11. Ding YS, Gatley SJ, Fowler JS, et al. Mapping nicotinic acetylcholine receptors with PET. Synapse. 1996;24:403-407.
12. 76Br]bromoepibatidine [abstract]. Soc Neurosci Ann Meeting. 1997;23:382.
13. Fisher M, Huangfu D, Shen TY, Guyenet PG. Epibatidine: an alkaloid from the poison frog Epipedobates tricolor is a powerful ganglionic depolarizing agent. J Pharmacol Exp Ther. 1994;270:702-707.
14. 3H]epibatidine binding to nicotinic cholinergic receptors in brain. Med Chem Res. 1994;4:538-546.
15. Lukas RJ. Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic binding sites by cells of the IMR-32 human neuroblastoma clonal line. J Pharmacol Exp Ther. 1993;265:294-302.
16. Molina PE, Ding YS, Carrol I, et al. Fluoro-norchloroepibatidine: preclinical assessment of acute toxicity. Nucl Med Biol. 1997;24:743-747.
17. Abreo MA, Lin NH, Garvey DS, et al. Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. J Med Chem. 1996;39:817-825.
18. Sullivan JP, Donelly-Roberts DL, Briggs CA, et al. A-85830 [3-(2(S)-azetidinylmethoxy)pyridine]: in vitro pharmacological properties of a novel high affinity alpha4 beta2 nicotinic acetylcholine receptor ligand. Neuropharmacol. 1996;35:725-734.
19. 3H]A-85380: a high-affinity neuronal nicotinic acetylcholine receptor radioligand [abstract]. Soc Neurosci Ann Meeting. 1995;21:606.
20. 18F]Fluoro-5-(2(S)-azetidinylmethoxy)-pyridine, a radioligand for in vivo imaging of central nicotinic receptors [abstract]. Soc Neurosci Ann Meeting. 1997;23:382.
21. 18F]-A-85380). J Labelled Compd Radiopharm. 1998;41:309-318.
22. 18F]fluoro3-[2(S)-2-azetidinylmethoxy]pyridine: a highly potent radioligand for in vivo imaging central nicotinic acetylcholine receptors. J Labelled Compd Radiopharm. 1998;41: 451-463.
23. Riche D, Hantraye P, Guibert B, et al. Anatomical atlas of the baboon's brain in the orbito-meatal plane used in experimental positron emission tomography. Brain Res Bull. 1988;20,283-287.
24. Villemagne VL, Horti A, Scheffel U, et al. Imaging nicotinic acetylcholine receptors with fluorine-18-FPH: an epibatidine analog. J Nucl Med. 1997;38:1737-1741.
25. Nordberg A, Alafuzoff I, Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J Neurosci Res. 1992;31:103-111.
26. Cimino M, Marini P, Fornasari D, Cattabeni F, Clementi F. Distribution of nicotinic receptors in cynomologus monkey brain and ganglia: localization of alpha 3 subunit mRNA, alpha-bungarotoxin and nicotine binding sites. Neuroscience. 1992;51:77-86.
27. Violet JM, Downie DL, Nasika RC, Lieb WR, Franks NP. Differential sensitivities of mammalian neuronal and muscle nicotinic acetylcholine receptors to general anesthetics. Anesthesiohgy. 1997;86:866-874.
28. Flood P, Ramirez-Latorre J, Role L. α4β2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but α4-type nicotinic acetylcholine receptors are unaffected. Anesthesiology. 1997;86:859-865.
29. 3H-epibatidine. Med Chem Res. 1994;4:528-537.
30. Bullock AE, Clark AL, Grady SR, et al. Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J Neurochem. 1997;68:2412-2423.